Cargando…

Increased detection of circulating tumor DNA by short fragment enrichment

BACKGROUND: Circulating cell-free DNA (cfDNA) detection for non-invasive diagnosis requires higher sensitivity and accuracy due to the low circulating tumor DNA (ctDNA) content. Many methods have been developed to improve detection of ctDNA, including ultra-deep sequencing or enrichment of shorter c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yang, Liu, Yangyang, Wang, Yingying, Li, Lei, Yao, Wenjun, Song, Yingnan, Liu, Bing, Chen, Weihuang, Santarpia, Mariacarmela, Rossi, Elisabetta, Zamarchi, Rita, Wang, Zhe, Wang, Qiming, Cheng, Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8044499/ https://www.ncbi.nlm.nih.gov/pubmed/33889525 http://dx.doi.org/10.21037/tlcr-21-180

Ejemplares similares

Single-Cell Analysis of Circulating Tumor Cells: How Far Have We Come in the -Omics Era?
por: Rossi, Elisabetta, et al.
Publicado: (2019)

Possible role of circulating tumor cells in early detection of lung cancer
por: Poggiana, Cristina, et al.
Publicado: (2020)

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations
por: Liu, Xiaojun, et al.
Publicado: (2020)

Circulating tumor DNA accurately predicts disease progression and genotype alterations in postoperative adjuvant EGFR-TKI resistance: a case report
por: Zeng, Zhen, et al.
Publicado: (2022)

Tumor immune microenvironment characterization and response to anti-PD-1 therapy
por: Santarpia, Mariacarmela, et al.
Publicado: (2015)

Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer()
por: Liu, Xiaoyu, et al.
Publicado: (2019)

Circulating tumor cells can predict the prognosis of patients with non-small cell lung cancer after resection: a retrospective study
por: Li, Zhao, et al.
Publicado: (2021)

The Interplay between Circulating Tumor Cells and the Immune System: From Immune Escape to Cancer Immunotherapy
por: Leone, Kevin, et al.
Publicado: (2018)

Detection and Prognostic Relevance of Circulating and Disseminated Tumour Cell in Dogs with Metastatic Mammary Carcinoma: A Pilot Study
por: Marconato, Laura, et al.
Publicado: (2019)

Baseline CD44v6-positive circulating tumor cells to predict first-line treatment failure in patients with metastatic colorectal cancer
por: Nicolazzo, Chiara, et al.
Publicado: (2020)

Clinical significance of circulating tumor cells and cell‐free DNA in pediatric rhabdomyosarcoma
por: Tombolan, Lucia, et al.
Publicado: (2022)

Cell-Secreted Vesicles: Novel Opportunities in Cancer Diagnosis, Monitoring and Treatment
por: Catoni, Cristina, et al.
Publicado: (2021)

Case Report: Circulating Tumor Cells as a Response Biomarker in ALK-Positive Metastatic Inflammatory Myofibroblastic Tumor
por: Bonvini, Paolo, et al.
Publicado: (2021)

Clinical relevance of the combined analysis of circulating tumor cells and anti-tumor T-cell immunity in metastatic breast cancer patients
por: Muraro, Elena, et al.
Publicado: (2022)

Short read DNA fragment anchoring algorithm
por: Wang, Wendi, et al.
Publicado: (2009)

Dynamic changes of Receptor activator of nuclear factor-κB expression in Circulating Tumor Cells during Denosumab predict treatment effectiveness in Metastatic Breast Cancer
por: Pantano, Francesco, et al.
Publicado: (2020)

Mosaicism in von Hippel-Lindau disease: an event important to recognize
por: Santarpia, Libero, et al.
Publicado: (2007)

Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer
por: Brisotto, Giulia, et al.
Publicado: (2020)

Automated size selection for short cell-free DNA fragments enriches for circulating tumor DNA and improves error correction during next generation sequencing
por: Hellwig, Sabine, et al.
Publicado: (2018)

Mechanisms of resistance to osimertinib
por: Lazzari, Chiara, et al.
Publicado: (2020)

Pediatric sarcomas display a variable EpCAM expression in a histology-dependent manner
por: Tombolan, Lucia, et al.
Publicado: (2020)

Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients
por: Rossi, Elisabetta, et al.
Publicado: (2013)

A fully automated assay to detect the expression of pan-cytokeratins and of EML4-ALK fusion protein in circulating tumour cells (CTCs) predicts outcome of non-small cell lung cancer (NSCLC) patients
por: Rossi, Elisabetta, et al.
Publicado: (2021)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer
por: Massafra, Marco, et al.
Publicado: (2020)

Overview on Therapeutic Options in Uncommon EGFR Mutant Non-Small Cell Lung Cancer (NSCLC): New Lights for an Unmet Medical Need
por: Pretelli, Giulia, et al.
Publicado: (2023)

Enrichment and single-cell analysis of circulating tumor cells
por: Song, Yanling, et al.
Publicado: (2017)

Circulating tumor cell methylation profiles reveal the classification and evolution of non-small cell lung cancer
por: Jiang, Jia-Hao, et al.
Publicado: (2022)

Clinical features and prognostic factors of combined small cell lung cancer: development and validation of a nomogram based on the SEER database
por: Yang, Lan, et al.
Publicado: (2021)

Human endogenous retroviruses and cancer
por: Gonzalez-Cao, María, et al.
Publicado: (2016)

Activation of viral defense signaling in cancer
por: Gonzalez-Cao, Maria, et al.
Publicado: (2018)

Accurate SNP and mutation detection by targeted custom microarray-based genomic enrichment of short-fragment sequencing libraries
por: Mokry, Michal, et al.
Publicado: (2010)

Inertial-Assisted Immunomagnetic Bioplatform towards Efficient Enrichment of Circulating Tumor Cells
por: Gou, Yixing, et al.
Publicado: (2021)

Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index
por: Beffagna, Giorgia, et al.
Publicado: (2017)

Potential treatment strategy for the rare osimertinib resistant mutation EGFR L718Q
por: Song, Yang, et al.
Publicado: (2020)

An exploration of the clinical progression models of osimertinib in the treatment of advanced EGFR-mutant non-small cell lung cancer
por: Shi, Yue, et al.
Publicado: (2022)

High-Efficiency Ion Enrichment inside Ultra-Short Carbon Nanotubes
por: Qiang, Yu, et al.
Publicado: (2022)

Prognostic value of circulating endothelial cells in glioblastoma patients: a pilot study
por: Vaz Salgado, María Angeles, et al.
Publicado: (2022)

Halogen-Enriched Fragment Libraries as Leads for Drug Rescue of Mutant p53
por: Wilcken, Rainer, et al.
Publicado: (2012)

Mining for viral fragments in methylation enriched sequencing data
por: Mensaert, Klaas, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pqo0ro9b1e3jm86o6jpg00n0ti